Diamedica Therapeutics Inc (DMAC)

Apr 13, 2026

EBITDA per share of DiaMedica Therapeutics Inc. – NASDAQ:DMAC - TradingView — Track All Markets

Apr 13, 2026

Apr 13, 2026

Is DiaMedica Therapeutics Inc a cyclical or defensive stock2026 Market Sentiment & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Returns Recap: How does DiaMedica Therapeutics Inc compare to its peers2026 Geopolitical Influence & Technical Entry and Exit Tips - baoquankhu1.vn

Apr 10, 2026

Apr 07, 2026

RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms - marketscreener.com

Apr 07, 2026

Apr 03, 2026

Q1 EPS Estimate for DiaMedica Therapeutics Raised by Analyst - MarketBeat

Apr 03, 2026

Apr 03, 2026

What is HC Wainwright’s Forecast for DMAC FY2029 Earnings? - Defense World

Apr 03, 2026

Apr 02, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pharmaceuticals (ORIC) - The Globe and Mail

Apr 02, 2026

Apr 02, 2026

HC Wainwright Issues Pessimistic Estimate for DMAC Earnings - MarketBeat

Apr 02, 2026

Apr 02, 2026

Top Wall Street forecasters revamp DiaMedica Therapeutics expectations ahead of Q4 earnings - MSN

Apr 02, 2026

Apr 01, 2026

[ARS] DiaMedica Therapeutics Inc. SEC Filing - Stock Titan

Apr 01, 2026

Apr 01, 2026

Equity plan expansion at DiaMedica (NASDAQ: DMAC) adds 3.5M shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

H.C. Wainwright reiterates DiaMedica stock rating on trial progress By Investing.com - Investing.com India

Apr 01, 2026

Apr 01, 2026

H.C. Wainwright reiterates DiaMedica stock rating on trial progress - Investing.com

Apr 01, 2026

Apr 01, 2026

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q4 2025 Earnings Call Transcript - Insider Monkey

Apr 01, 2026

Mar 31, 2026

DiaMedica Therapeutics Furnishes 2025 Financial Results and Business Update - The Globe and Mail

Mar 31, 2026

Mar 31, 2026

DMAC Should I Buy - Intellectia AI

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Inc (DMAC) Q4 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Inc.Common Stock - FinancialContent

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Reports 2025 Financial Results - National Today

Mar 31, 2026

Mar 31, 2026

DiaMedica reiterates plan for ReMEDy2 interim analysis in 2H 2026 as stroke trial approaches 70% of 200 patients - MSN

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Q4 Earnings Call Highlights - MarketBeat

Mar 31, 2026

Mar 31, 2026

Earnings call transcript: DiaMedica Therapeutics Q4 2025 shows liquidity boost By Investing.com - Investing.com South Africa

Mar 31, 2026

Mar 31, 2026

Earnings call transcript: DiaMedica Therapeutics Q4 2025 shows liquidity boost - Investing.com

Mar 31, 2026

Mar 31, 2026

DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights - BioSpace

Mar 31, 2026

Mar 30, 2026

Loss Report: Is DiaMedica Therapeutics Inc a cyclical or defensive stockTrade Analysis Report & AI Optimized Trading Strategy Guides - baoquankhu1.vn

Mar 30, 2026

Mar 30, 2026

DiaMedica Therapeutics (DMAC) Strengthens Financial Position and Advances Clinical Programs - GuruFocus

Mar 30, 2026

Mar 30, 2026

Rising R&D widens loss as DiaMedica (NASDAQ: DMAC) funds DM199 - Stock Titan

Mar 30, 2026

Mar 30, 2026

DiaMedica Therapeutics (NASDAQ:DMAC) Issues Quarterly Earnings Results, Meets Expectations - MarketBeat

Mar 30, 2026

Mar 30, 2026

DiaMedica Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Mar 30, 2026

Mar 30, 2026

DM199 pipeline: DiaMedica Therapeutics (NASDAQ: DMAC) targets stroke and preeclampsia - Stock Titan

Mar 30, 2026

Mar 30, 2026

Top Wall Street Forecasters Revamp DiaMedica Therapeutics Expectations Ahead Of Q4 Earnings - Benzinga

Mar 30, 2026

Mar 29, 2026

DiaMedica Therapeutics, Inc. (NASDAQ:DMAC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Mar 29, 2026

Mar 27, 2026

DiaMedica Therapeutics Inc expected to post a loss of 18 cents a shareEarnings Preview - TradingView

Mar 27, 2026

Mar 27, 2026

Price Action: Can DiaMedica Therapeutics Inc keep up with sector leadersRate Cut & Weekly Watchlist of Top Performers - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

Can DiaMedica Therapeutics Inc keep up with sector leadersRate Cut & Weekly Watchlist of Top Performers - baoquankhu1.vn

Mar 27, 2026

Mar 24, 2026

DiaMedica Therapeutics (DMAC) Projected to Post Earnings on Tuesday - Defense World

Mar 24, 2026

Mar 23, 2026

DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026 - weeklyvoice.com

Mar 23, 2026

Mar 23, 2026

DiaMedica schedules March 31 call for 2025 results, business update - Stock Titan

Mar 23, 2026

Mar 18, 2026

DiaMedica Therapeutics appoints Julie Krop as Chief Medical Officer - MSN

Mar 18, 2026

Mar 17, 2026

Market Review: How does DiaMedica Therapeutics Inc compare to its peers2026 Technical Patterns & Expert Verified Movement Alerts - baoquankhu1.vn

Mar 17, 2026

Mar 15, 2026

Cooperman Leon G Raises Position in DiaMedica Therapeutics, Inc. $DMAC - MarketBeat

Mar 15, 2026

Mar 14, 2026

Does DiaMedica Therapeutics (DMAC) Have the Potential to Rally 114.06% as Wall Street Analysts Expect? - MSN

Mar 14, 2026

Mar 10, 2026

DiaMedica receives Health Canada clearance for preeclampsia study - Investing.com Nigeria

Mar 10, 2026

Mar 10, 2026

Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Codexis (CDXS) and Diamedica Therapeutics (DMAC) - The Globe and Mail

Mar 10, 2026